NM_175882.3:c.314C>T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_175882.3(SPPL2C):c.314C>T(p.Thr105Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000531 in 1,613,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_175882.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152150Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000291 AC: 73AN: 250688Hom.: 0 AF XY: 0.000273 AC XY: 37AN XY: 135662
GnomAD4 exome AF: 0.000563 AC: 823AN: 1461580Hom.: 0 Cov.: 30 AF XY: 0.000536 AC XY: 390AN XY: 727078
GnomAD4 genome AF: 0.000223 AC: 34AN: 152268Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74442
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.314C>T (p.T105M) alteration is located in exon 1 (coding exon 1) of the SPPL2C gene. This alteration results from a C to T substitution at nucleotide position 314, causing the threonine (T) at amino acid position 105 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at